Jazz Pharmaceuticals plc Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Nanotechnology in Cancer Treatment (PHM222B)

Vyxeos (daunorubicin and cytarabine)

This drug combines daunorubicin and cytarabine, two chemotherapy drugs that inhibit cancer cell growth and DNA formation. It is used to treat certain types of leukemia, specifically newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). It is suitable for adults and children aged one year or older.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.